RenovoRx
RNXT
12 hedge funds and large institutions have $482K invested in RenovoRx in 2022 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 5 closing their positions.
60% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 5
33% more funds holding
Funds holding: 9 → 12 (+3)
21% more capital inflows, than outflows
Capital inflows: $523K | Capital outflows: $432K
0.68% more ownership
Funds ownership: 1.17% → 1.85% (+0.68%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LBC
Lawrence B. Cohen
|
+$190K |
| 2 |
Stifel Financial
St. Louis,
Missouri
|
+$102K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$65.1K |
| 4 |
Colony Group
Boston,
Massachusetts
|
+$54.3K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$51.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Board of Trustees of The Leland Stanford Junior University
Redwood City,
California
|
-$295K |
| 2 |
Virtu Financial
New York
|
-$64K |
| 3 |
Verition Fund Management
Greenwich,
Connecticut
|
-$50K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$22K |
| 5 |
CHA
Carmichael Hill & Associates
Gaithersburg,
Maryland
|
-$1K |
RNXT Hedge Fund Activity: Q1 2022 in Review
12 of the 6,363 institutional investors tracked by Wall St. Rank reported a position in RenovoRx (RNXT) for Q1 2022, worth a combined $482K — down 4.7% from $506K a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new RNXT positions and 5 closed out — a net gain of 3 holders — while 2 added to existing stakes and 0 trimmed.
The largest buyer was Lawrence B. Cohen, opening a new position worth an estimated $190K. The largest seller was Board of Trustees of The Leland Stanford Junior University, exiting entirely with an estimated $295K sold.
- 12 institutional investors held RenovoRx (RNXT) as of Q1 2022, up from 9 in Q4 2021.
- Funds reported $482K of RenovoRx stock for Q1 2022, down 4.7% quarter-over-quarter.
- 8 funds opened new RenovoRx positions in Q1 2022 and 5 closed out, a net change of +3 holders.
- The largest RenovoRx buyer in Q1 2022 was Lawrence B. Cohen, an estimated $190K added.
- The largest RenovoRx seller in Q1 2022 was Board of Trustees of The Leland Stanford Junior University, an estimated $295K sold.
Based on aggregated 13F filings for Q1 2022.